Vitamin A exhibits dual protective and pathogenic roles in diabetes mellitus by modulating β-cell function
Background
The global burden of diabetes mellitus necessitates a deeper understanding of its pathogenesis and potential therapeutic targets. Pancreatic β-cell dysfunction, including impaired insulin secretion and survival, is central to both type 1 and type 2 diabetes. While vitamin A is classically known for its roles in vision and immunity, emerging evidence suggests it acts as a critical modulator of glucose homeostasis. However, its precise, context-dependent influence on β-cell health and diabetes progression has remained complex and not fully elucidated, presenting a significant gap in nutritional and therapeutic strategies.
Study Design
This comprehensive review systematically analyzed the relationship between vitamin A status and diabetes mellitus, integrating findings from a wide array of clinical, epidemiological, and experimental studies published up to 2025. The authors meticulously examined the impact of vitamin A on pancreatic β-cell function, morphology, and survival. Their analysis covered the intricate processes of vitamin A absorption, metabolism, and its underlying molecular mechanisms, aiming to clarify its complex roles in diabetes pathogenesis and identify areas for future research.
Results
The review revealed that vitamin A plays a multifaceted role in diabetes, exhibiting both protective and potentially pathogenic effects. It significantly influences β-cell development, enhances insulin secretion, and offers protection against oxidative and inflammatory damage. In the context of type 1 diabetes, retinoids were found to reduce autoimmune responses, promote immune tolerance, and contribute to the preservation of β-cell mass. For type 2 diabetes, vitamin A modulates specific insulin secretion pathways and impacts β-cell gene expression. However, the review also highlighted a critical caveat: > High circulating levels of retinol and retinol-binding protein 4 (RBP4) may paradoxically contribute to insulin resistance, indicating a context-dependent dual role. Conversely, carotenoids, a subgroup of vitamin A compounds, consistently appeared protective against diabetes progression.
Key Findings
- Vitamin A influences β-cell development, insulin secretion, and protection against oxidative/inflammatory damage.
- In type 1 diabetes, retinoids reduce autoimmune responses, promote immune tolerance, and preserve β-cell mass.
- In type 2 diabetes, vitamin A modulates insulin secretion pathways and β-cell gene expression.
- High circulating retinol and retinol-binding protein 4 (
RBP4) may contribute to insulin resistance. - Carotenoids appear protective against diabetes progression and complications.
Why It Matters
This review underscores the critical need for a nuanced understanding of vitamin A in diabetes management, moving beyond simple deficiency or excess. For individuals managing diabetes or at risk, this suggests that personalized nutritional strategies regarding vitamin A intake may be crucial, distinguishing between different forms (retinoids vs. carotenoids) and considering individual metabolic profiles. While not a direct protocol, the findings highlight that high retinol supplementation could be detrimental in some contexts, whereas carotenoid-rich foods might be beneficial. This research clarifies mechanisms, paving the way for targeted dietary interventions or novel therapeutic approaches that leverage vitamin A's protective effects while mitigating its potential adverse impacts on insulin sensitivity. Further research is needed to translate these mechanistic insights into precise clinical guidelines.
vitamin-a
diabetes
type-1-diabetes
type-2-diabetes
beta-cell-function
insulin-secretion